FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

703673007: Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3009237018 SGLT2 inhibitor - Sodium glucose cotransporter subtype 2 inhibitor en Synonym Inactive Entire term case sensitive SNOMED CT core module
3009365018 Sodium glucose cotransporter subtype 2 inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3009684010 Sodium glucose cotransporter subtype 2 inhibitor (substance) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3520826018 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3559322015 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module

10 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Is a Antidiabetic agent false Inferred relationship Existential restriction modifier
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Is a Drug or medicament true Inferred relationship Existential restriction modifier
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Has disposition Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Existential restriction modifier
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Is a Substance with cellular transport inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dapagliflozin Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Canagliflozin Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Empagliflozin Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing sodium glucose cotransporter subtype 2 inhibitor Has active ingredient True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Ertugliflozin Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dapagliflozin propanediol Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Canagliflozin hemihydrate Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dapagliflozin propanediol monohydrate Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ertugliflozin pidolate Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Remogliflozin etabonate Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ertugliflozin L-pyroglutamic acid Is a True Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start